α1-antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α

American Journal of Respiratory Cell and Molecular Biology

Volumn 49, Issue 1, 2013, Pages 143-150

  Lockett, Angelia D ^a   Kimani, Samuel ^a   Ddungu, Godfrey ^a   Wrenger, Sabine ^b   Tuder, Rubin M ^c   Janciauskiene, Sabina M ^b   Petrache, Irina ^a  

^a INDIANA UNIVERSITY   (United States)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

COPD; Inflammation; Proteinase inhibitor; Serpin; Vascular

Indexed keywords

ALPHA 1 ANTITRYPSIN; CALPAIN; CHLOROTRIANISENE; I KAPPA B ALPHA; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUCIFERASE; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATION; INFLAMMATORY CELL; LUNG; LUNG ENDOTHELIAL CELL; LUNG ENDOTHELIUM; MACROPHAGE ACTIVATION; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEINASE INHIBITION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ADAM PROTEINS; ALPHA 1-ANTITRYPSIN; ANIMALS; CALPAIN; CELL MEMBRANE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-1BETA; LUNG; PEPTIDE FRAGMENTS; PRIMARY CELL CULTURE; PROTEOLYSIS; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883190759     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0515OC     Document Type: Article

References (49)

1. Strieter RM, Lukacs NW, Standiford TJ, Kunkel SL. Cytokines: 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung. Thorax 1993;48:765-769.
2. Doerschuk CM. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 2001;8:71-88.
3. Grau GE, Mili N, Lou JN, Morel DR, Ricou B, Lucas R, Suter PM. Phenotypic and functional analysis of pulmonary microvascular endothelial cells from patients with acute respiratory distress syndrome. Lab Invest 1996;74:761-770.
4. Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR, Tuder RM. {Alpha}-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 2006;169:1155-1166.
5. Petrache I, Fijalkowska I, Zhen L, Medler TR, Brown E, Cruz P, Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Shapiro L, et al. A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 2006;173:1222-1228.
6. Aldonyte R, Jansson L, Piitulainen E, Janciauskiene S. Circulating monocytes from healthy individuals and COPD patients. Respir Res 2003;4:11-18.
7. Churg A, Wang X, Wang RD, Meixner SC, Pryzdial EL, Wright JL. Alpha1-antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages. Am J Respir Cell Mol Biol 2007;37:144-151.
8. Janciauskiene SM, Nita IM, Stevens T. Alpha1-antitrypsin, old dog, new tricks: alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem 2007;282:8573-8582.
9. Pott GB, Chan ED, Dinarello CA, Shapiro L. Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol 2009;85:886-895.
10. Tawara I, Sun Y, Lewis EC, Toubai T, Evers R, Nieves E, Azam T, Dinarello CA, Reddy P. Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 2011;109:564-569.
11. Lindström FD, Skogh T, Lundström IMC. A1 antitrypsin deficiency in a patient with systemic vasculitis and primary Sjögren's syndrome. Ann Rheum Dis 2002;61:945-946.
12. Cooper EH, Ward AM. Acute phase reactant proteins as aids to monitoring disease. Invest Cell Pathol 1979;2:293-301.
13. Black LF, Kueppers F. Alpha1-antitrypsin deficiency in nonsmokers. Am Rev Respir Dis 1978;117:421-428.
14. Janus ED, Phillips NT, Carrell RW. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet 1985;1:152-154.
15. Hubbard RC, Ogushi F, Fells GA, Cantin AM, Jallat S, Courtney M, Crystal RG. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J Clin Invest 1987;80:1289-1295.
16. Carp H, Miller F, Hoidal JR, Janoff A. Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci USA 1982;79:2041-2045.
17. Taggart C, Cervantes-Laurean D, Kim G, McElvaney NG, Wehr N, Moss J, Levine RL. Oxidation of either methionine 351 or methionine 358 in a1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem 2000;275:27258-27265.
18. Orosz Z, Csiszar A, Labinskyy N, Smith K, Kaminski PM, Ferdinandy P, Wolin MS, Rivera A, Ungvari Z. Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. Am J Physiol Heart Circ Physiol 2007;292: H130-H139.
19. Imaizumi T, Itaya H, Fujita K, Kudoh D, Kudoh S, Mori K, Fujimoto K, Matsumiya T, Yoshida H, Satoh K. Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1 beta. Arterioscler Thromb Vasc Biol 2000;20:410-415.
20. Bergin DA, Reeves EP, Meleady P, Henry M, McElvaney OJ, Carroll TP, Condron C, Chotirmall SH, Clynes M, O'Neill SJ, et al. Alpha-1 antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin Invest 2010;120:4236-4250.
21. Churg A, Wang RD, Xie C, Wright JL. Alpha-1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2003;168:199-207.
22. Aldonyte R, Hutchinson ET, Jin B, Brantly M, Block E, Patel J, Zhang J. Endothelial alpha-1-antitrypsin attenuates cigarette smoke induced apoptosis in vitro. COPD 2008;5:153-162.
23. Lockett AD, Van Demark M, Gu Y, Schweitzer KS, Sigua N, Kamocki K, Fijalkowska I, Garrison J, Fisher AJ, Serban K, et al. Effect of cigarette smoke exposure and structural modifications on the alpha-1 antitrypsin interaction with caspases. Mol Med 2012;18:445-454.
24. Sohrab S, Petrusca DN, Lockett AD, Schweitzer KS, Rush NI, Gu Y, Kamocki K, Garrison J, Petrache I. Mechanism of {alpha}-1 antitrypsin endocytosis by lung endothelium. FASEB J 2009;23:3149-3158.
25. Subramaniyam D, Virtala R, Pawlowski K, Clausen IG, Warkentin S, Stevens T, Janciauskiene S. TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin. Int J Biochem Cell Biol 2008;40:258-271.
26. Lee A, Whyte M, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993;54:283-288.
27. Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarencon D, Agay D, Chancerelle Y, Multon E. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 2004;5:3.
28. Yoshida T, Mett I, Bhunia AK, Bowman J, Perez M, Zhang L, Gandjeva A, Zhen L, Chukwueke U, Mao T, et al. RTP801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med 2010;16:767-773.
29. Strieter RM, Kunkel SL, Showell HJ, Remick DG, Phan SH, Ward PA, Marks RM. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science 1989; 243:1467-1469.
30. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 1991;138:447-453.
31. López-Bojórquez LN, Arechavaleta-Velasco F, Vadillo-Ortega F, Móntes-Sánchez D, Ventura-Gallegos JL, Zentella-Dehesa A. Nf-kB translocation and endothelial cell activation is potentiated by macrophage-released signals co-secreted with TNF-a and IL-1b. Inflamm Res 2004;53:567-575.
32. Han S-J, Ko H-M, Choi J-H, Seo KH, Lee H-S, Choi E-K, Choi I-W, Lee H-K, Im S-Y. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kB (NF-kB). J Biol Chem 2002; 277:44715-44721.
33. Han Y, Brasier AR. Mechanism for biphasic REL A: NF-kB1 nuclear translocation in tumor necrosis factor a-stimulated hepatocytes. J Biol Chem 1997;272:9825-9832.
34. Xanthoulea S, Pasparakis M, Kousteni S, Brakebusch C, Wallach D, Bauer J, Lassmann H, Kollias G. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases. J Exp Med 2004;200:367-376.
35. Cook EB, Stahl JL, Graziano FM, Barney NP. Regulation of the receptor for TNFalpha, TNFR1, in human conjunctival epithelial cells. Invest Ophthalmol Vis Sci 2008;49:3992-3998.
36. Bell JH, Herrera AH, Li Y, Walcheck B. Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages. J Leukoc Biol 2007;82:173-176.
37. Al-Omari M, Korenbaum E, Ballmaier M, Lehmann U, Jonigk D, Manstein DJ, Welte T, Mahadeva R, Janciauskiene S. Acute-phase protein alpha1-antitrypsin inhibits neutrophil calpain I and induces random migration. Mol Med 2011;17:865-874.
38. Lewis EC, Shapiro L, Bowers OJ, Dinarello CA. Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci USA 2005;102:12153-12158.
39. Greene CM, Miller SD, Carroll TP, Oglesby IK, Ahmed F, O'Mahony M, Taggart CC, McElvaney NG, O'Neill SJ. Anti-apoptotic effects of Z alpha1-antitrypsin in human bronchial epithelial cells. Eur Respir J 2010;35:1155-1163.
40. Toldo S, Seropian IM, Mezzaroma E, Van Tassell BW, Salloum FN, Lewis EC, Voelkel N, Dinarello CA, Abbate A. Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 2011;51:244-251.
41. Berda-Haddad Y, Robert S, Salers P, Zekraoui L, Farnarier C, Dinarello CA, Dignat-George F, Kaplanski G. Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1alpha. Proc Natl Acad Sci USA 2011;108:20684-20689.
42. Lewis EC. Expanding the clinical indications for alpha(1)-antitrypsin therapy. Mol Med 2012;18:957-970.
43. Finotti P, Pagetta A. A heat shock protein 70 fusion protein with alpha1-antitrypsin in plasma of Type 1 diabetic subjects. Biochem Biophys Res Commun 2004;315:297-305.
44. Bahbouhi B, Bendjennat M, Guetard D, Seidah NG, Bahraoui E. Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication. Biochem J 2000;352:91-98.
45. Bahbouhi B, Seidah NG, Bahraoui E. Replication of HIV-1 viruses in the presence of the Portland alpha1-antitrypsin variant (alpha1-PDX) inhibitor. Biochem J 2001;360:127-134.
46. Congote LF. The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1. Biochem Biophys Res Commun 2006;343:617-622.
47. Shapiro L, Pott GB, Ralston AH. Alpha-1-antitrypsin inhibits human immunodeficiency virus Type 1. FASEB J 2001;15:115-122.
48. Churg A, Dai J, Zay K, Karsan A, Hendricks R, Yee C, Martin R, MacKenzie R, Xie C, Zhang L, et al. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest 2001;81:1119-1131.
49. Ekstrom MP, Wagner P, Strom KE. Trends in cause-specific mortality in oxygen-dependent chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;183:1032-1036.